SCB-1019T

· Clover Biopharmaceuticals AUS Pty

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SCB-1019T, covering 2024-12-31 to 2025-06-06. Get the full timeline:

Most recent: Clinical Trial Update: First-in-human Safety and Immunogenicity Study of SCB-1019 and SCB-1019T in Healthy Adults [Phase 1]